4
Changes in Ownership
Dolby Laboratories, Inc. Filed Acc 0001193125-25-207589
President and CEO sold 25,000 shares at $71.66 ($1,791,490)
- President and CEO acquired 25,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
YEAMAN KEVIN J · President and CEO
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-09-16 | Exercise or conversion : show line 1 in the form 10b5-1 | +25,000 | $45.50 | $1,137,500 | 139,725 | I |
| 2025-09-16 | Sale : show line 2 in the form 10b5-1 | −25,000 | $71.66 | $1,791,490 | 114,725 | I |
| Open-market sales · 25,000 sh · avg $71.66 · $1,791,490 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-09-16 | Exercise or conversion : show line 3 in the form 10b5-1 Employee Stock Option (Right to Buy) | −25,000 | 60,615 | I |
Loading xslF345X05/ownership.xml…